Wearable metric

Blood pressure

BP · Home BP monitoring · Hypertension screening

The single most modifiable cardiovascular risk factor. Home monitoring is more informative than the occasional office reading.

Strong relevance10 cited sourcesNo fasting€40–120 for a home device; free at most pharmacies and GP visits. 24-hour ambulatory monitoring €80–200 private.movementstressnutrition

What it measures

The pressure of arterial blood against vessel walls during systole (peak) and diastole (trough), reported in mmHg. Office, home, and 24-hour ambulatory monitoring each capture slightly different signals; home and ambulatory generally outperform office measurement for risk prediction.

Reference context

5 guideline sources

Office vs home thresholds differ: 140/90 office ≈ 135/85 home/ambulatory daytime average. SPRINT used research-grade unattended automated office BP, which reads ~5–10 mmHg lower than standard office BP. Apparent threshold differences (US 130 vs EU 140) partly reflect measurement-protocol differences; ESC 2024 now flags 120–139/70–89 as elevated and recommends a treated systolic target of 120–129 for most adults.

Population context: consult guideline targets below

Mechanism

Why moving this marker matters

Sustained elevated blood pressure drives endothelial damage, vascular remodelling, and target-organ injury (heart, brain, kidney, retina). It is the single largest modifiable contributor to cardiovascular disease burden globally. SPRINT (2015, n=9,361) demonstrated that intensive systolic targets (<120 mmHg) vs standard (<140 mmHg) reduced major cardiovascular events by 25% and all-cause mortality by 27% in non-diabetic adults at elevated risk.

Guideline targets

What major guidelines recommend

ESC 2024 (non-elevated)

Strong

<120 / <70 mmHg (office)

ESC 2024 (elevated)

Strong

120–139 / 70–89 mmHg (office)

ESC 2024 (hypertension)

Strong

≥140 / ≥90 mmHg (office)

ESC 2024 (treatment target)

Strong

Systolic 120–129 mmHg for most adults on treatment, if tolerated

ACC/AHA 2017

Strong

Hypertension threshold ≥130 / 80 mmHg

How to measure

The test, where to get it, when to repeat

Method

Validated upper-arm oscillometric cuff (Omron, Withings BPM Core, Boso, A&D). Seated, back supported, feet flat, arm at heart level, after 5 minutes of rest, no caffeine/exercise/smoking in the prior 30 minutes. Take two readings 1 minute apart, twice daily (morning + evening) for 7 days; average days 2–7.

Where

Home monitor (€40–120 for a validated device), GP office, pharmacy, or via 24-hour ambulatory cuff arranged through a clinician.

Typical cost

€40–120 for a home device; free at most pharmacies and GP visits. 24-hour ambulatory monitoring €80–200 private.

Fasting

Not required

When to test

  • USPSTF 2021

    18+

    Annual screening for adults 40+; every 3–5 years for adults 18–39 at low risk. Home or ambulatory confirmation before diagnosing hypertension.

  • ESC/ESH 2018

    Risk-based re-measurement: at least every 5 years if BP is optimal, every 3 years if normal, at least yearly if high-normal. Out-of-office readings recommended for diagnostic confirmation.

  • ACC/AHA 2017 (Whelton)

    Routine screening; emphasis on out-of-office measurement and team-based care.

  • NICE NG136 (UK)

    Ambulatory or home BP monitoring required to confirm hypertension if office reading is 140/90 or higher.

How to track

Devices and apps that measure this

These consumer wearables and connected devices report this metric. Healicus is not connected to your device. Your data lives in the maker's app and never reaches us.

Healicus is not the provider. Your contract for the service is with whoever you choose. Links labelled Sponsored are paid affiliate relationships; unlabelled links are editorial reference only. See our disclosure for the full policy.

Context

Reading the numbers

Office vs home thresholds differ: 140/90 office ≈ 135/85 home/ambulatory daytime average. SPRINT used research-grade unattended automated office BP, which reads ~5–10 mmHg lower than standard office BP. Apparent threshold differences (US 130 vs EU 140) partly reflect measurement-protocol differences; ESC 2024 now flags 120–139/70–89 as elevated and recommends a treated systolic target of 120–129 for most adults.

Caveats

White-coat effect (artificially elevated office readings) and masked hypertension (normal office, elevated home) are both common. Out-of-office confirmation is essential before lifelong treatment decisions. Cuff size matters: undersized cuffs over-read by 5–10 mmHg. Readings of 180/120 or higher, especially with headache, chest pain, breathlessness or vision change, need same-day medical help (NICE NG136).

Practices

What's been shown to influence this marker

DASH-Sodium RCT (n=412): clinically meaningful systolic reductions (~6–11 mmHg in hypertensive participants), comparable to first-line monotherapy.

PREDIMED (NEJM 2018): a Mediterranean diet supplemented with extra-virgin olive oil or nuts led to fewer major cardiovascular events than a reduced-fat control diet. That report did not give blood-pressure changes, so the size of any BP effect is not established from it.

Aerobic exercise reduces resting systolic BP by ~5–8 mmHg in hypertensive adults and ~2–4 mmHg in normotensive adults (meta-analyses).

In a meta-analysis of 36 trials (Roerecke 2017), cutting down lowered blood pressure in people drinking more than about 2 drinks a day, with larger falls at higher intakes (about 5.5 mmHg systolic in those drinking 6 or more drinks a day who roughly halved their intake); no clear effect at 2 drinks a day or fewer.

Mediterranean dietary patternHabit
Moderate evidence

Mediterranean dietary pattern

Olive oil, fish, nuts, legumes, plants. Two randomised trials found fewer major cardiovascular events than a low-fat diet.

Read full evidence

Why

The Mediterranean pattern, heavy on plants, olive oil, fish, nuts, legumes; moderate fish and dairy; light on red meat, has randomised-trial evidence for fewer major cardiovascular events than a low-fat diet in adults at high cardiovascular risk. PREDIMED, the largest trial (republished after protocol deviations), showed ~30% fewer major cardiovascular events vs. low-fat control. Trial evidence for cognition is thin.

Slot in your day

With a meal

How to do it

How

Olive oil as the primary fat. Plants at every meal. Fish 2–3× per week. Nuts daily (small handful). Red meat once a week or less. Alcohol is not needed for the pattern; low-volume drinking has not been shown to be protective.

Sticking with it

Stock the kitchen for one week's pattern. Decisions live in the shopping list, not at mealtime.

Markers this may influence

Evidence

At a glance

Estruch 2018 N Engl J Med RCT (n=7,447, adults at high cardiovascular risk, republished after protocol deviations): a Mediterranean diet with olive oil or nuts had fewer major cardiovascular events than a control diet advising less fat (hazard ratios 0.69 and 0.72). Delgado-Lista 2022 Lancet RCT (n=1,002, coronary heart disease) found a similar direction versus a low-fat diet, mainly in men. Trial evidence for cognition is thin.

GRADE certainty: Moderate — rated by Healicus using the GRADE method (RCT evidence; downgraded for protocol deviations/no blinding in the main trials and for indirectness of dietary-pattern comparisons)

DASH dietary patternHabit
Moderate evidence

DASH dietary pattern

Dietary Approaches to Stop Hypertension. Lowered blood pressure in a randomised feeding trial.

Read full evidence

Why

DASH emphasises vegetables, fruits, whole grains, low-fat dairy, lean protein, and limited sodium, sweets, and saturated fat. In the landmark NEJM feeding trial (Sacks 2001, n=412), DASH combined with low sodium gave systolic pressure 11.5 mm Hg lower in people with hypertension and 7.1 mm Hg lower in those without, versus a typical US diet at high sodium; DASH alone lowered it by less. Each sodium level was fed for 30 days, and the outcome was blood pressure, not cardiovascular events.

Slot in your day

With a meal

How to do it

How

Vegetables and fruits at every meal (~4-5 servings each per day). Whole grains over refined. Limit red meat, sweets, and sugar-sweetened drinks. Cap sodium at ~1,500-2,300 mg/day. Two weeks of consistent eating typically shows BP changes.

Ideal for

People with elevated or borderline blood pressure.

Markers this may influence

Evidence

At a glance

Sacks 2001 N Engl J Med RCT (n=412): the DASH diet with low sodium gave average systolic pressure 11.5 mm Hg lower in adults with hypertension and 7.1 mm Hg lower in those without, compared with a typical US diet at high sodium. Blood pressure was lower on DASH at every sodium level, and sodium reduction lowered it on either diet.

GRADE certainty: Moderate — rated by Healicus using the GRADE method (one controlled feeding trial, blood pressure as a surrogate outcome, 30-day feeding periods)

Zone 2 cardioHabit
Moderate evidence

Zone 2 cardio

Conversational-pace cardio, 150+ minutes per week, in line with WHO's moderate-intensity guideline.

Read full evidence

Why

Zone 2 is the intensity at which you can still hold a conversation but a song would be a stretch, roughly 60–70% of max heart rate. This exact intensity has not been tested; WHO strongly recommends 150–300 minutes a week of moderate-intensity aerobic activity for adults, and cohort studies link that kind of activity to lower all-cause mortality. Sustained Zone 2 work is proposed to increase mitochondrial density and improve fat oxidation.

Slot in your day

Anytime

How to do it

How

Brisk walk, easy bike, slow jog. 30 minutes × 5 days, or 45–60 min × 3 days. The 'talk test' is the simplest gauge.

Ideal for

Anyone over 30; especially valuable as the foundation before adding higher-intensity work.

Sticking with it

Schedule it like a meeting. The session you 'fit in if there's time' is the session that doesn't happen.

Markers this may influence

Evidence

At a glance

WHO's 2020 physical activity guidelines strongly recommend 150-300 minutes a week of moderate-intensity aerobic activity for adults, on moderate-certainty evidence of lower all-cause and cardiovascular mortality. Kelly 2014 Int J Behav Nutr Phys Act meta-analysis of cohort studies: about 11 MET-hours a week of walking or cycling was associated with 11% and 10% lower all-cause mortality. The specific 'zone 2' intensity was not tested.

GRADE certainty: Moderate — reported by WHO 2020 guidelines (moderate certainty for aerobic activity of 150-300 min/week)

Limit alcohol intakeCautionHabit
Preliminary evidence

Limit alcohol intake

Meta-analysis of 107 cohort studies: drinking 45 g or more of alcohol a day was linked to higher all-cause mortality, while low-volume drinking showed no significant difference.

Read full evidence

Why

A 2023 JAMA Network Open meta-analysis of 107 cohort studies (n=4,838,825) found higher all-cause mortality in people drinking 45 g or more of alcohol per day than in lifetime nondrinkers, with women at higher risk. Low-volume drinking showed no significant mortality difference once biases were corrected, so light drinking is not shown to be protective. The US Preventive Services Task Force advises screening and brief counselling for adults who drink above recommended limits.

How to do it

How

Track intake honestly for one week. If above threshold, set a weekly cap rather than a daily one (avoids the 'I'll catch up' trap). Several alcohol-free days per week is the simplest pattern. Sleep quality typically improves within 1-2 weeks of reduced intake.

Ideal for

Anyone currently drinking heavily or above recommended limits.

Markers this may influence

Caution: Sudden cessation in heavy drinkers can cause withdrawal, taper or seek medical guidance if you've been drinking heavily for years.

Evidence

At a glance

Zhao 2023 JAMA Netw Open meta-analysis of 107 cohort studies (n=4,838,825): drinkers of 45 g or more of alcohol per day had higher all-cause mortality than lifetime nondrinkers (RR 1.19 and 1.35), while low-volume drinking showed no significant difference. The US Preventive Services Task Force (2018) recommends screening adults and offering brief counselling to those drinking above recommended limits.

GRADE certainty: Low — rated by Healicus using the GRADE method

Reduce ultra-processed foodHabit
Preliminary evidence

Reduce ultra-processed food

Higher ultra-processed food intake is associated with higher mortality in observational studies; whether cutting it lowers risk is untested.

Read full evidence

Why

Foods classified as ultra-processed (NOVA group 4), packaged snacks, sweetened drinks, reformulated meats, ready meals, are associated with higher cardiovascular and all-cause mortality, type 2 diabetes and depression in observational studies. These show association, not that cutting them lowers risk. Proposed mechanisms include altered satiety signalling, additive effects, and displacement of whole foods.

Slot in your day

Anytime

How to do it

How

Aim for the bulk of the diet to be foods you'd recognise in a kitchen 100 years ago. Convenience foods are fine occasionally; the issue is when they become the default.

Sticking with it

Don't fight cravings in front of the cupboard, fight them at the supermarket.

Markers this may influence

Evidence

At a glance

Lane 2024 BMJ umbrella review of 45 meta-analyses (n=9,888,373): higher ultra-processed food intake was associated with greater cardiovascular mortality (risk ratio 1.50, very low GRADE certainty) and type 2 diabetes, with highly suggestive links to all-cause mortality and depression. Taneri 2022 and Pagliai 2021 meta-analyses found similar associations. All data were observational, so causation is unproven.

GRADE certainty: Low — rated by Healicus using the GRADE method

See also

Related markers

Take to your physician

Worth discussing

  • Whether your home-monitoring pattern reflects sustained hypertension vs white-coat effect vs masked hypertension.
  • Which BP target applies to you (ESC 2024: systolic 120–129 mmHg for most treated adults if tolerated; targets are individualised for older or frail adults).
  • If you're already on antihypertensive therapy, whether the medication class (ACEi/ARB/CCB/thiazide) fits your other conditions and side-effect tolerance.
  • Whether you should be checked for secondary causes (primary aldosteronism, OSA, renal artery stenosis) if BP is treatment-resistant.

Sources

Cited literature

Last reviewed October 2026

Educational reference. Population-level information for the longevity-curious reader. Healicus does not compute scores, interpret your specific values, or produce personalised recommendations from your clinical data. Discuss your own results and any decisions with your physician.

Keep reading